Scienture Holdings, Inc. (NASDAQ:SCNX) Sees Significant Increase in Short Interest

Scienture Holdings, Inc. (NASDAQ:SCNX) saw a large increase in short interest in July. As of July 15th, there was short interest totaling 2,600,386 shares, an increase of 177.8% from the June 30th total of 935,988 shares. Approximately 8.1% of the shares of the company are short sold. Based on an average trading volume of 7,329,646 shares, the days-to-cover ratio is currently 0.4 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Scienture in a research report on Wednesday, June 24th. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $1.50.

Scienture Stock Up 2.2%

SCNX stock traded up $0.01 during mid-day trading on Tuesday, reaching $0.38. 101,085 shares of the stock traded hands, compared to its average volume of 2,194,227. Scienture has a 52 week low of $0.24 and a 52 week high of $2.60. The business has a 50-day moving average of $0.38 and a two-hundred day moving average of $0.41. The firm has a market capitalization of $15.24 million, a PE ratio of -0.15 and a beta of 3.28.

Scienture (NASDAQ:SCNX) last posted its quarterly earnings data on Friday, May 15th. The company reported ($0.08) EPS for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.15. The business had revenue of $0.06 million during the quarter, compared to the consensus estimate of $0.40 million.

Institutional Investors Weigh In On Scienture

An institutional investor recently bought a new position in Scienture stock. Virtu Financial LLC acquired a new position in shares of Scienture Holdings, Inc. (NASDAQ:SCNX) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 89,930 shares of the company’s stock, valued at approximately $46,000. Virtu Financial LLC owned 0.22% of Scienture at the end of the most recent reporting period. 5.68% of the stock is currently owned by institutional investors and hedge funds.

About Scienture

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.